Medication at transitions in care with Ciara Kirke
Date: 6 March 2017
Presenter: Ciara Kirke, Clinical Lead, National Medication Safety Programme, Quality Improvement Division, Health Service Executive, Ireland
Track 2: Patient Centred Care
"This webinar was highly beneficial. It gave me more insights of how to manage medications better and consider patient safety in an environment of manpower shortage.The medication reconciliation and the role of the nurse in taking medication history during admission.In addition, the poll survey shared an opinion from other healthcare providers across the continents. Thank you so much for conducting this webinar. Much appreciation to ISQua, Yulianna for facilitating and Dr. Ciara Kirke for imparting your expertise in your field."
Nurse Supervisor, Saudi Arabia
"Focused on the reliability of med rec being performed by nurses as opposed to pharmacists. I particularly enjoyed the good balance between evidence and practical application. We are dealing with the implementation in the home care sector by third party providers. Thank you for an excellent and timely presentation!”
Director Quality, Risk and Professional Practice, Canada
About the Webinar
Our traditional healthcare systems are set up to ensure most patients transitioning from one healthcare setting to another are affected by unintentional discrepancies in their medication, with harm resulting in many cases. Reconciling and communicating medication at every transition presents a considerable challenge. Evidence-based cost-effective solutions are available. The most effective, pharmacy-led medication reconciliation processes, require dedicated resources. Empowered patients, improved information technology and education and training can also improve performance, along with improved electronic or paper forms. This webinar will discuss the problem and potential solutions, illustrated by case studies where significant improvement has been achieved.
By the end of this webinar, learners will:
- Understand the scale and nature of the problem of incomplete medication reconciliation at transitions.
- Understand the components of good practice to achieve successful reconciliation and communication at transitions.
- Gain an understanding of the types of interventions which can address and improve medication management at transitions, together with the evidence-base and economic case for their use.
- Learn from some exemplars of practice.
- Consider a pathway towards improvement.
Healthcare professionals and others involved in medication-related aspects of patient care across transitions. Doctors, pharmacists, nurses, healthcare assistants, administrators and others, working in hospital, primary care, social care, residential care, should find it of interest, in addition to those involved in patient safety, risk management and quality improvement.
About the Presenter
(MPSI, MSc (Clin Pharm), BSc (Pharm), Dip LQH, GDip RMQ), IA). Ms Kirke is a pharmacist with 20 years experience in healthcare. She joined the Quality Improvement Division of the Health Service Executive in Ireland in 2015 as Clinical Lead, National Medication Safety Programme. The HSE is the central body responsible for all public health and residential social care in Ireland. Her work centres around reducing patient harm associated with medicines or their omission via collaborative work with healthcare organisations.
Prior to this, her role as Medication Safety Manager in a university hospital for over 10 years centred around a patient safety reporting and learning system, together with applying quality improvement to improve patient safety. She has also worked in clinical pharmacy, medicines information and other areas of hospital pharmacy in hospitals in Ireland and Scotland as well as in community pharmacy and industry.
Ciara has post-graduate qualifications in Clinical Pharmacy, Risk Management, Quality Improvement and has recently completed the Improvement Advisor programme with the Institute for Healthcare Improvement.
Ciara acts as a medication error expert and is a member of the Naming Review Group for the European Medicines Agency. She is a member of national and international medication safety groups, including the International Medication Safety Network. She has been participating in the development of the upcoming World Health Organisation Patient Safety Challenge in Medication Safety, particularly concerning Transitions of Care.